Ugro Capital Appoints New Auditors, Reappoints MD & VP
Ugro Capital's Board meeting on April 20, 2026, approved FY26 audited financials with an unmodified auditor opinion. Mr. Shachindra Nath was recommended for re-appointment as Vice Chairman & MD. M/s G.P. Kapadia & Co. will be appointed as new statutory auditors. The company also approved NCD issuance up to ₹3,000 crore.
The re-appointment of the MD and the appointment of new auditors are significant governance events. The approval for NCD issuance up to ₹3,000 crore indicates potential future fundraising which can impact the company's capital structure and growth plans.
The announcement includes routine financial reporting, leadership changes, and auditor appointments, which are standard corporate governance activities. While the re-appointment of the MD is positive, the change in auditors and the approval of NCDs are neutral events without immediate positive or negative financial implications stated.
Ugro Capital Limited announced key changes following its Board Meeting on April 20, 2026. The company approved the audited financial statements for the fiscal year ended March 31, 2026, including both consolidated and standalone results for the quarter and full year. The auditors, M/s Sharp & Tannan Associates, issued an unmodified opinion on these results.
In significant leadership news, the Board recommended the re-appointment of Mr. Shachindra Nath as Vice Chairman and Managing Director for a five-year term, effective June 22, 2026, subject to shareholder approval. Concurrently, the tenure of the current statutory auditors, M/s Sharp & Tannan Associates, will conclude at the upcoming 33rd Annual General Meeting (AGM). The Board has approved the appointment of M/s G.P. Kapadia & Co. as the new statutory auditors for a three-year period, commencing from the conclusion of the ensuing AGM, pending shareholder approval.
Furthermore, the company approved the issuance of Non-Convertible Debentures (NCDs) aggregating up to ₹3,000 crores on a private placement basis. The Board also recommended granting Employee Stock Options to employees of its subsidiaries, subject to shareholder consent. The 33rd AGM of the company is scheduled to be held on Friday, May 29, 2026.
What to do with a filing like this
Ugro Capital Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Ugro Capital Limited. Read the original for the full detail.